|
Volumn 10, Issue 3, 2001, Pages 269-272
|
Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: Early termination due to excessive toxicity
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
GLUTATHIONE TRANSFERASE;
OLTIPRAZ;
OXIDOREDUCTASE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;
SYNTHETASE;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CHEMOPROPHYLAXIS;
CONJUNCTIVITIS;
CONTROLLED STUDY;
ENZYME ACTIVITY;
FATIGUE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
RASH;
SMOKING;
ACETYLCYSTEINE;
ADULT;
AGED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FATIGUE;
FEMALE;
GASTROINTESTINAL DISEASES;
HUMANS;
MALE;
MIDDLE AGED;
PYRAZINES;
REFERENCE VALUES;
RISK ASSESSMENT;
SMOKING;
|
EID: 0035730760
PISSN: 10559965
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (15)
|